Kamata R, Yamamoto T, Matsumoto K, Maeda H
Infect Immun. 1985 Jun;48(3):747-53. doi: 10.1128/iai.48.3.747-753.1985.
The 56-kilodalton (56K) protease isolated from a culture filtrate of Serratia marcescens caused vascular permeability enhancement followed by edema formation when injected into guinea pig peripheral corneas and subconjunctival space or skin. The character and the mechanism of permeability enhancement were analyzed in vivo. The enhancement was maximum at 5 to 10 min. The permeability reaction increased exponentially by the amount of enzyme used. The enhancement of permeability induced by the 56K protease was not affected by treatment with an antihistamine but was greatly augmented by simultaneous injection of a kinin potentiator, Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH (SQ 20,881). Furthermore, the permeability activity of the protease, but not the amidolytic activity, was inhibited by soybean trypsin inhibitor, a well-known inhibitor of plasma kallikrein, as well as by corn trypsin inhibitor, the best inhibitor of activated Hageman factor. Results of these in vivo studies indicate that the permeability-enhancing reaction induced by the 56K protease is caused by activation of the Hageman factor-dependent pathway in the tissue. The permeability-increasing activity of the 56K protease was parallel with the enzyme activity. Serratial lipopolysaccharide did not produce a permeability enhancement reaction within 30 min when injected into guinea pig skin. These results are consistent with the results of recent in vitro experiments in which activation of the purified Hageman factor but not of prekallikrein by the 56K protease was elucidated (Matsumoto et al., J. Biochem. (Tokyo) 96:739-749, 1984). Thus, the molecular mechanism described above appears to be operative in the pathogenesis of corneal edema and chemosis, which is induced by S. marcescens, in addition to the direct tissue destruction by the protease.
从粘质沙雷氏菌培养滤液中分离出的56千道尔顿(56K)蛋白酶,注射到豚鼠外周角膜、结膜下间隙或皮肤后,会导致血管通透性增强,随后形成水肿。在体内分析了通透性增强的特征和机制。增强作用在5至10分钟时达到最大值。通透性反应随所用酶量呈指数增加。56K蛋白酶诱导的通透性增强不受抗组胺药处理的影响,但同时注射激肽增强剂Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH(SQ 20,881)会使其大大增强。此外,蛋白酶的通透性活性而非酰胺水解活性受到大豆胰蛋白酶抑制剂(一种众所周知的血浆激肽释放酶抑制剂)以及玉米胰蛋白酶抑制剂(活化的哈格曼因子的最佳抑制剂)的抑制。这些体内研究结果表明,56K蛋白酶诱导的通透性增强反应是由组织中哈格曼因子依赖性途径的激活引起的。56K蛋白酶的通透性增加活性与酶活性平行。将粘质沙雷氏菌脂多糖注射到豚鼠皮肤中,在30分钟内未产生通透性增强反应。这些结果与最近的体外实验结果一致,在该实验中阐明了56K蛋白酶可激活纯化的哈格曼因子而非前激肽释放酶(松本等人,《生物化学杂志》(东京)96:739 - 749,1984)。因此,除了蛋白酶对组织的直接破坏外,上述分子机制似乎在粘质沙雷氏菌诱导的角膜水肿和球结膜水肿的发病机制中起作用。